Genentech, Inc., based in South San Francisco, CA, is a leader in biopharmaceutical innovations, focusing on the development of advanced therapies for serious medical conditions. The company specializes in areas such as NLRP3 modulators, Bruton's tyrosine kinase inhibitors, and immunoconjugates, contributing significantly to cancer treatment and therapeutic antibodies. Genentech also leverages deep learning and polypeptide production technologies to enhance drug discovery and development, positioning itself at the forefront of biotechnological advancements.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

3,302 Patents

#1 in South San Francisco, CA

#35 in California

#136 in US

#283 in the World

South San Francisco, CA, United States of America

Genentech, Inc.

Forward Citations = 67,917

2,651 inventors:

William I Wood (643 out of 667 patents)

Austin L Gurney (613 out of 719 patents)

Audrey Goddard (602 out of 632 patents)

4. Paul J Godowski (569 out of 594 patents)

5. Victoria Smith (285 out of 312 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Genentech, Inc.. Retrieved from https://idiyas.com/company/genentech

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

131 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

619 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]